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Abstract
Background. The project to develop a new Japanese Ortho-
paedic Association (JOA) score rating system for low back 
disorders, the JOA Back Pain Evaluation Questionnaire 
(JOABPEQ), is currently in progress. Part 1 of the study 
selected 25 “candidate” items for use on the JOABPEQ. The 
purpose of this current Part 2 of the study was to verify the 
reliability of the questionnaire.
Methods. A total of 161 patients with low-back disorders of 
any type participated in the study. Each patient was inter-
viewed twice at an interval of 2 weeks using the same ques-
tionnaire. The reliability of the questionnaire was evaluated 
by determining the extension of the kappa and weighted 
kappa coefﬁ  cients.
Results.  Both kappa and weighted kappa were more than 
0.50 for all but one item, which was 0.48. The lower 95% con-
ﬁ  dence interval exceeded 0.4 in all but two items, which was 
0.39. This implied that the test–retest reliability of JOABPEQ 
was acceptable as a measure of outcome.
Conclusions. The tentative questionnaire of the JOABPEQ 
with 25 items was conﬁ  rmed to be reliable enough to describe 
the quality of life of patients who suffer low back disorders.
Introduction
Measurement of the outcome is critical for any decision-
making and results of evaluations in all medical circum-
stances. This should be applicable when managing 
patients who have lumbar spine-related problems. The 
Japan Orthopaedic Association (JOA) developed and 
published a speciﬁ  c instrument to measure outcomes 
for patients with low back problems in 1986.
1 It was 
called the JOA score rating system for low back pain, 
with a full score being 29 points. Since then, the instru-
ment has been widely utilized to evaluate the functional 
results of many types of intervention for patients with 
such problems. It has been referred to not only in arti-
cles by Japanese investigators
2 but also in those by non-
Japanese-speaking investigators.
3,4  One of the major 
criticisms of this speciﬁ  c instrument, however, is that it 
is not a patient-oriented measurement but a physician-
based one. It is now widely accepted that a patient’s 
perspective is essential for making medical decisions 
and for evaluating the results of interventions.
5 Based 
on the current needs for measuring outcome, the JOA 
was urged to revise its original score rating system and 
to develop a new one. In 2002, a Subcommittee on 
Evaluation of Back Pain and Cervical Myelopathy was 
organized in the Clinical Outcome Committee of JOA, 
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and work began on revising the original JOA scoring 
system.
This revision process consisted of four steps: Parts 1 
to 4. As described in the previous literature concerning 
Part 1, the original JOA scoring system was revised and 
a new scoring system (the JOA Back Pain Evaluation 
Questionnaire — JOABPEQ) was developed.
6 The key 
points of this revision were to make the original JOA 
score more patient-oriented. For the survey in the Part 
1 study, we ﬁ  rst created a preliminary questionnaire 
consisting of 60 items. The questionnaire was a self-
administered, disease-speciﬁ  c measure that was created 
with reference to the Japanese editions of the short 
form health survey with 36 questions (SF-36)
7 and the 
Roland-Morris Disability Questionnaire (RDQ)
8  to 
assess health-related quality of life. From the survey, a 
total of 25 items were selected for tentative use on a 
draft of the JOABPEQ (Table 1).
Table 1.  Items (n = 25) selected for the draft of the JOABPEQ evaluated in this study
With regard to your health condition during the last week, please circle the item number of the answer for the following 
questions that best applies. If your condition varies depending on the day or time, circle the item number when your condition is 
at its worst.
Q1-1. To alleviate low back pain, you often change your posture.
1) Yes
2) No
Q1-2.  Because of low back pain, you do not do any routine housework these days.
1) No
2) Yes
Q1-3.  Because of low back pain, you lie down more often than usual.
1) Yes
2) No
Q1-4.  Because of low back pain, you sometimes ask someone to help you when you do something.
1) Yes
2) No
Q1-5.  Because of low back pain, you refrain from bending forward or kneeling down.
1) Yes
2) No
Q1-6.  Because of low back pain, you have difﬁ  culty standing up from a chair.
1) Yes
2) No
Q1-7. Your lower back aches most of the time.
1) Yes
2) No
Q1-8.  Because of low back pain, turning over in bed is difﬁ  cult.
1) Yes
2) No
Q1-9.  Because of low back pain, you have difﬁ  culty putting on socks or stockings.
1) Yes
2) No
Q1-10.  Because of low back pain, you walk only short distances.
1) Yes
2) No
Q1-11.  Because of low back pain, you cannot sleep well. (If you take sleeping pills because of the pain, select “No.”)
1) No
2) Yes
Q1-12.  Because of low back pain, you stay seated most of the day.
1) Yes
2) No
Q1-13.  Because of low back pain, you become irritated or angry at other persons more often than usual.
1) Yes
2) No
Q1-14.  Because of low back pain, you go up stairs more slowly than usual.
1) Yes
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Q2-1.  How is your present health condition?
1) Excellent
2) Very good
3) Good
4) Fair
5) Poor
Q2-2.  Do you have difﬁ  culty in climbing stairs?
1)  I have great difﬁ  culty.
2)  I have some difﬁ  culty.
3)  I have no difﬁ  culty.
Q2-3.  Do you have difﬁ  culty in any one of the following motions: bending forward, kneeling, or stooping?
1)  I have great difﬁ  culty.
2)  I have some difﬁ  culty.
3)  I have no difﬁ  culty.
Q2-4.  Do you have difﬁ  culty walking more than 15 minutes?
1)  I have great difﬁ  culty.
2)  I have some difﬁ  culty.
3)  I have no difﬁ  culty.
Q2-5.  Have you been unable to do your work or ordinary activities as well as you would like?
1)  I have not been able to do them at all.
2)  I have been unable to do them most of the time.
3)  I have sometimes been unable to do them.
4)  I have been able to do them most of the time.
5)  I have always been able to do them.
Q2-6.  Has your work routine been hindered because of the pain?
1) Greatly
2) Moderately
3) Slightly (somewhat)
4) Little (minimally)
5) Not at  all
Q2-7.  Have you been discouraged or depressed?
1) Always
2) Frequently
3) Sometimes
4) Rarely
5) Never
Q2-8.  Do you feel exhausted?
1) Always
2) Frequently
3) Sometimes
4) Rarely
5) Never
Q2-9.  Do you feel happy?
1) Always
2) Almost always
3) Sometimes
4) Rarely
5) Never
Q2-10.  Do you think you are in reasonable health?
1) Yes (I am healthy.)
2)  Fairly (my health is better than average)
3)  Not (very much)/particularly (my health is average)
4)  Barely (my health is poor)
5)  Not at all (my health is very poor)
Q2-11.  Do you feel your health will get worse?
1) Very much so
2) A little at a time
3)  Sometimes yes and sometimes no
4) Not very  much
5) Not at  all
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The purpose of the Part 2 study in this project was to 
evaluate the reliability of the 25 items selected for the 
draft JOABPEQ; for this, test–retest reliability was 
ascertained.
Materials and methods
Recruitment of patients
Altogether, 460 of the 829 Japanese board-certiﬁ  ed 
spine surgeons were randomly selected, and each was 
asked to recruit two patients to evaluate the JOABPEQ 
between January and June 2004. The recruited patients 
were scheduled to reply to the questionnaire twice at a 
2-week interval. Patient criteria were as follows: (1) 
patients could be any age of either sex; (2) patients had 
any lumbar spine disorder and were currently visiting 
an outpatient clinic; (3) the severity of the symptoms 
was expected to be at the same level between the two 
interviews. Exclusion criteria were the presence of: (1) 
other musculoskeletal diseases requiring medical treat-
ment; (2) psychiatric disease (e.g., dementia), potentially 
leading to inappropriate answers; (3) a postoperative 
condition; (4) having participated in previous surveys of 
the related study.
Testing the questionnaire
Each patient was asked to complete the same question-
naire twice at an interval of 2 weeks (±3 days). The 
attending surgeon ﬁ  lled out the patient information on 
the diagnosis and the presence or absence of concomi-
tant diseases, followed by judging the severity of symp-
toms using a three-step rating scale (mild, moderate, 
severe). Symptom severity was determined subjectively 
by the attending surgeon, who was asked not to select 
a similar patient solely on the basis of severity. Patients 
who had the same level of severity as judged by all sur-
geons were then selected and analyzed to verify the 
reliability of the questionnaire.
This study was approved by the Ethics Committee of 
the Japanese Society for Spine Surgery and Related 
Research. Informed consent was obtained from each 
patient.
The reliability of the questionnaire was evaluated by 
determining the extension of the kappa coefﬁ  cients. The 
weighted kappa coefﬁ  cient was calculated in the items 
with three choices or more. The kappa and weighted 
kappa coefﬁ  cients were calculated based on a formula 
using Microsoft Ofﬁ  ce Excel 2003. Kappa and weighted 
kappa coefﬁ  cients of 0.4 or above were judged to be 
reliable.
9 The 95% conﬁ  dence intervals (95% CI) were 
calculated for all reliability coefﬁ  cients using the boot-
strap method.
Results
Patient characteristics
A total of 350 patients participated in this study and 
completed the questionnaire twice following the pro-
ject’s plan. However, 135 patients were excluded because 
the severity of their symptoms had changed between the 
two interviews or they violated the interval period. Of 
the remaining 215 patients, 54 were ineligible because 
of other musculoskeletal diseases, such as knee and hip 
osteoarthrosis. As a result, a total of 161 patients were 
available for the analysis in this study: 86 men and 75 
women with a mean age of 57.7 years (SD 16.3 years). 
The clinical diagnosis included degenerative lumbar 
canal stenosis in 49 patients, lumbar disc herniation in 
44, spondylolisthesis in 20, spondylosis in 16, degenera-
tive disc disease in 13, mechanical low back pain in 11, 
and miscellaneous in 8. The patients’ age varied from 
their twenties to their eighties, and symptom severity 
varied from mild to severe (Table 2). Neurological and 
physical status was evaluated for each patient using the 
current JOA score rating system and ﬁ  nger–ﬂ  oor dis-
tance (Table 3). Neurological deﬁ  cits varied from mild 
to severe, and trunk ﬂ  exibility varied among the subjects 
as well.
Face validity
Face validity was checked in terms of the completion 
rate for ﬁ  lling out the questionnaire. The distribution of 
Table 2.  Distribution of age and severity of symptoms in the patients 
analyzed (n = 161)
Age (years)
No. of patients, by severity of symptoms
Mild Moderate Severe Total
Men
  20– 2 2 3 7
  30– 4 4 1 9
  40– 2 2 0 4
  50– 7 9 1 17
  60– 13 8 3 24
  70– 6 18 0 24
  80– 0 0 1 1
  Total 34 43 9 86
Women
  20– 2 3 0 5
  30– 4 5 0 9
  40– 6 1 1 8
  50– 9 4 1 14
  60– 7 11 1 19
  70– 8 9 1 18
  80– 1 1 0 2
  Total 37 34 4 75
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the answers for all question items was then checked to 
ensure that there were no biased answers. Items remain-
ing unanswered accounted for less than 5% in the ﬁ  rst 
test, and there was no skewed distribution, such as “ﬂ  oor 
and ceiling” effects (Table 4).
Reliability
The test–retest reliability was conﬁ  rmed by calculating 
the kappa and weighted kappa coefﬁ  cients for each item 
(Tables 5A, 5B). Both kappa and weighted kappa were 
more than 0.50 in all items, except in one item with 0.48. 
The lower 95% CI exceeded 0.4 in all items, except in 
two items with 0.39. This implied that the test–retest 
reliability of JOABPEQ was acceptable as a measure-
ment of outcome.
Discussion
Measurement of the outcome is generally divided into 
two categories: generic and disease-speciﬁ  c measures.
5,10 
SF-36 has been commonly used as representative of a 
measurement of generic health status.
5,7,10 The RDQ and 
the Oswestry Disability Index are widely used as disease-
speciﬁ  c measurements for back pain.
8,11 The JOA score 
rating system for low back pain, developed in 1986, was 
also a disease-speciﬁ  c measuring instrument for back 
disorders and injuries and has been widely utilized in 
clinical research and the decision-making process in 
Japan. However, this is not a patient-based outcome 
measure reliable enough to describe the objective status 
of the function and quality of life (QOL) of patients 
with low-back disorders. There has, to date, been insuf-
ﬁ  cient psychometric analysis to conﬁ  rm the validity and 
reliability of this JOA score rating system.
The project for developing the new questionnaire, 
JOABPEQ, was initiated to create a self-administered, 
disease-speciﬁ  c method for measuring low back pain. 
This instrument should include functions of the lumbar 
spine as well as health-related QOL. The reliability of 
the questionnaire that includes the 25 suggested items 
was evaluated using psychometric analysis as Part 2 of 
this project. Kappa and weighted kappa coefﬁ  cient were 
utilized to verify the test–retest reliability.
12,13
In terms of external validity, biased data were inevi-
table because one criterion that was included was that 
the severity of the symptoms was expected to be at the 
same level between the two interviews. However, there 
was no bias on the choices of answer to each question. 
This implies that test–retest reliability was acceptable 
even if the subjects had symptoms of different severity. 
The older the patients were, the worse was the interpre-
tation of each question. There were small numbers of 
patients of younger generations, such as those in their 
thirties and forties, in this study. Thus, the reliability 
would not deteriorate even if the number of young 
people were to increase.
In terms of English expression, there is a possibility 
of ambiguity in questions 1-2 and 1-11, where double 
negatives (two “no’s” in the answer) may be confusing. 
It is necessary to reconsider and revise the English 
expression so it is more easily understood by native 
English-language users. The number of choices for the 
answer in all questions varied from two to ﬁ  ve, which is 
also a point to be reconsidered in the future.
The current study demonstrated that the 25 items had 
enough reliability to describe the QOL in patients suf-
fering low back disorders. However, further studies are 
needed to complete the project, including a factor anal-
ysis to determine the underlying cluster of the question-
naire items, a formula for calculating the severity score, 
and conﬁ  rmation of the responsiveness to the 
questionnaire.
Table  3.  Current Japanese Orthopaedic Association score 
rating system and ﬁ  nger to ﬂ  oor distance for the patients 
analyzed (n = 161)
Parameter No.
SLR test
  Normal 124
  30°–70° 35
  <30° 2
Motor function
  Normal 113
  Slight weakness (MMT: good) 38
  Severe weakness (MMT: less than good) 10
Sensory function
  Normal 80
  Slight disturbance 59
  Severe disturbance 22
Bladder function
  Normal 147
  Mild dysuria 12
  Severe dysuria 2
Finger to ﬂ  oor distance (cm)
∼−15 1
−14∼−5 17
  −4~−4 41
  5~14 40
  15~24 32
  25~34 9
  35~44 7
  45~54 7
  55~64 4
  65~74 1
Immeasurable 2
Total no. 161
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Table 4.  Reproducibility of each item (n = 161)
Item
Choices for answer
No answer 12 3 4 5
Q1-1 117 43 1
72.7% 26.7% 0.6%
Q1-2 32 127 2
19.9% 78.9% 1.2%
Q1-3 76 83 2
47.2% 51.6% 1.2%
Q1-4 42 119
26.1% 73.9%
Q1-5 77 84
47.8% 52.2%
Q1-6 31 130
19.3% 80.7%
Q1-7 68 93
42.2% 57.8%
Q1-8 65 95 1
40.4% 59.0% 0.6%
Q1-9 72 89
44.7% 55.3%
Q1-10 87 74
54.0% 46.0%
Q1-11 35 122 4
21.7% 75.8% 2.5%
Q1-12 41 119 1
25.5% 73.9% 0.6%
Q1-13 36 125
22.4% 77.6%
Q1-14 115 45 1
71.4% 28.0% 0.6%
Q2-1 18 59 66 16 2
11.2% 36.6% 41.0% 9.9% 1.2%
Q2-2 15 92 52 2
9.3% 57.1% 32.3% 1.2%
Q2-3 25 93 38 5
15.5% 57.8% 23.6% 3.1%
Q2-4 35 70 55 1
21.7% 43.5% 34.2% 0.6%
Q2-5 15 12 85 35 13 1
9.3% 7.5% 52.8% 21.7% 8.1% 0.6%
Q2-6 13 36 66 32 11 3
8.1% 22.4% 41.0% 19.9% 6.8% 1.9%
Q2-7 12 8 79 39 22 1
7.5% 5.0% 49.1% 24.2% 13.7% 0.6%
Q2-8 8 27 88 24 12 2
5.0% 16.8% 54.7% 14.9% 7.5% 1.2%
Q2-9 8 42 74 31 5 1
5.0% 26.1% 46.0% 19.3% 3.1% 0.6%
Q2-10 13 59 42 34 12 1
8.1% 36.6% 26.1% 21.1% 7.5% 0.6%
Q2-11 17 48 56 28 11 1
10.6% 29.8% 34.8% 17.4% 6.8% 0.6%532  M. Fukui et al.: JOA Back Pain Questionnaire: Part 2
Table 5A.  Kappa coefﬁ  cient with 95% CI for items Q1-1 to 
Q1-14
Item κ 95% CI
Q1-1 0.69 0.60–0.77
Q1-2 0.62 0.51–0.73
Q1-3 0.67 0.60–0.75
Q1-4 0.65 0.56–0.75
Q1-5 0.48 0.39–0.57
Q1-6 0.55 0.43–0.66
Q1-7 0.65 0.57–0.73
Q1-8 0.55 0.47–0.64
Q1-9 0.71 0.64–0.78
Q1-10 0.63 0.55–0.72
Q1-11 0.50 0.39–0.61
Q1-12 0.56 0.46–0.65
Q1-13 0.65 0.55–0.74
Q1-14 0.72 0.64–0.80
CI, conﬁ  dence interval
Table 5B. Weighted kappa coefﬁ  cient with 95% CI for items 
Q2-1 to Q2-11
Item Weighted κ 95% CI
Q2-1 0.51 0.43–0.57
Q2-2 0.61 0.52–0.68
Q2-3 0.57 0.49–0.64
Q2-4 0.73 0.68–0.78
Q2-5 0.54 0.47–0.60
Q2-6 0.61 0.55–0.67
Q2-7 0.53 0.46–0.59
Q2-8 0.55 0.48–0.61
Q2-9 0.54 0.46–0.60
Q2-10 0.54 0.47–0.61
Q2-11 0.53 0.46–0.60
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Conclusions
The tentative JOABPEQ with 25 items was conﬁ  rmed 
to be reliable enough to describe the QOL of patients 
suffering low back disorders.